• Erratum to ¡®Next-generation sequencing analysis of hepatitis C virus resistance?associated substitu...

• Kim Kyung-Ah

• Lee Se-Joon, Park Hye-Jung, Jang Eun-Sun, Lee Youn-Jae, Cho Sung-Bum, Kim Young-Seok, Kim ...

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 830 ~ 830

• Erratum to ¡®Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis...

• Oh Joo-Hyun

• Sinn Dong-Hyun

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 828 ~ 829

• HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?

• Lee Soon-Kyu

• Kwon Jung-Hyun

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 825 ~ 827

• Correspondence on Letter 2 regarding ¡°Assessing the performance of ChatGPT in answering questions r...

• Yee Hui Yeo

• Jamil S. Samaan, Wee Han Ng

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 823 ~ 824

• Correspondence on Letter 1 regarding ¡°Assessing the performance of ChatGPT in answering questions r...

• Yee Hui Yeo

• Jamil S. Samaan, Wee Han Ng

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 821 ~ 822

• Correspondence on Letter regarding ¡°Is liver biopsy essential to identifying the immune tolerant ph...

• Oh Joo-Hyun

• Sinn Dong-Hyun

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 820 ~ 820

• Correspondence on Letter regarding ¡°Non-alcoholic fatty liver disease: Definition and subtypes¡±

• Han Seul-Ki

• Baik Soon-Koo, Kim Moon-Young

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 817 ~ 819

• Letter 2 regarding ¡°Assessing the performance of ChatGPT in answering questions regarding cirrhosis...

• Amnuay Kleebayoon

• Viroj Wiwanitkit

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 815 ~ 816

• Letter 1 regarding ¡°Assessing the performance of ChatGPT in answering questions regarding cirrhosis...

• Hassam Ali

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 813 ~ 814

• Letter regarding ¡°Is liver biopsy essential to identifying the immune tolerant phase of chronic hep...

• Halil Haldun Emiroglu

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 812 ~ 812

• Letter regarding ¡°Non-alcoholic fatty liver disease: Definition and subtypes¡±

• Jeong Seog-Song

• Lim Yo-Hwan, Lee Su-Kyoung, Han Hyun-Wook

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 810 ~ 811

• Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma

• Park Jea-Yeon

• Chung Sung-Won, Lee Yun-Bin, Shin Hyun-Jae, Hur Moon-Haeng, Cho Hee-Jin, Park Min-Kyung, Y...

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 794 ~ 809

• Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A na...

• Lee Chang-Hun

• Choi Gwang-Hyeon, Choi Hwa-Young, Han So-Jung, Jang Eun-Sun, Chon Young-Eun, Chang Young, ...

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 779 ~ 793

• Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with po...

• Hur Moon-Haeng

• Cho Yu-Ri, Kim Do-Young, Lee Jae-Seung, Kim Gyoung-Min, Kim Hyo-Cheol, Sinn Dong-Hyun, Hyu...

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 763 ~ 778

• Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in ...

• Xiaoning Wu

• Xiaoqian Xu, Jialing Zhou, Yameng Sun, Huiguo Ding, Wen Xie, Guofeng Chen, Anlin Ma, ...

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 747 ~ 762

• Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and...

• Hwang Yoon-Jung

• Bae Jae-Seok, Kim Ji-Hyun, Hur Bo-Yun, Lee Dong-Ho, Kim Hae-Ryoung

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 733 ~ 746

• Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular c...

• Yee Hui Yeo

• Kim Young-Min, Seo Seon-Mi, Kwon Oh-Shin, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Do...

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 721 ~ 732

• Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched ...

• Yu Jun Wong

• Seo Haeng-Ran, Hwai-I Yang, Jie Li, Michael Huan Le, Wan-Jung Wu, Nicole Xinrong Han, Khi ...

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 705 ~ 720

• Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoho...

• Park Min-Jeong

• Kim Ha-Yeon, Kim Myeong-Gyu, Kim Kyung-Im

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 693 ~ 704

• The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic ...

• Xianhua Mao

• Lung Yi Mak, Wai-Kay Seto

• Clinical and Molecular Hepatology   2023  Volume.29  No.3 690 ~ 692